Abstract
Approximately 15% of cerebral strokes in adults are due to bleeding into the brain (intracerebral hemorrhage, ICH). This can be related to hypertension, vascular anomalies, or coagulopathy. Prognosis following ICH is worse than that following ischemic stroke. In addition, head trauma and premature birth are associated with ICH. Inflammation occurs after ICH and might be an important part of the pathogenesis of brain damage. The goal of this review is to bring together recent diverse data concerning inflammation after ICH. There has been little investigation of the role of inflammation following ICH despite the fact that inflammation is more severe than in ischemic stroke. Inflammation in the brain follows a temporal sequence similar to that in other organs. Some cytokines and inflammatory cells may possess dual roles both deleterious and beneficial to brain after ICH. At present, experimental data only weakly support pursuit of pharmacologic anti-inflammatory strategies following ICH.
Keywords: inflammation, cytokines, adhesion molecules, leukocytes, ich, brain trauma, animal models, anti-inflammation
Current Neuropharmacology
Title: Brain Inflammation Following Intracerebral Hemorrhage
Volume: 1 Issue: 4
Author(s): Mengzhou Xue, Janani Balasubramaniam and Marc R. Del Bigio
Affiliation:
Keywords: inflammation, cytokines, adhesion molecules, leukocytes, ich, brain trauma, animal models, anti-inflammation
Abstract: Approximately 15% of cerebral strokes in adults are due to bleeding into the brain (intracerebral hemorrhage, ICH). This can be related to hypertension, vascular anomalies, or coagulopathy. Prognosis following ICH is worse than that following ischemic stroke. In addition, head trauma and premature birth are associated with ICH. Inflammation occurs after ICH and might be an important part of the pathogenesis of brain damage. The goal of this review is to bring together recent diverse data concerning inflammation after ICH. There has been little investigation of the role of inflammation following ICH despite the fact that inflammation is more severe than in ischemic stroke. Inflammation in the brain follows a temporal sequence similar to that in other organs. Some cytokines and inflammatory cells may possess dual roles both deleterious and beneficial to brain after ICH. At present, experimental data only weakly support pursuit of pharmacologic anti-inflammatory strategies following ICH.
Export Options
About this article
Cite this article as:
Xue Mengzhou, Balasubramaniam Janani and Bigio R. Del Marc, Brain Inflammation Following Intracerebral Hemorrhage, Current Neuropharmacology 2003; 1 (4) . https://dx.doi.org/10.2174/1570159033477008
DOI https://dx.doi.org/10.2174/1570159033477008 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
The Role of the RhoA/rho-kinase Pathway in Pulmonary Hypertension
Current Drug Discovery Technologies Prognostic Significance of Asymptomatic Myocardial Ischemia in Women vs. Men
Current Pharmaceutical Design Dietary Regulation of Glucose Metabolism in Metabolic Syndrome
Current Vascular Pharmacology Metabolic Profiling in Multiple Sclerosis and Other Disorders by Quantitative Analysis of Cerebrospinal Fluid Using Nuclear Magnetic Resonance Spectroscopy
Current Pharmaceutical Biotechnology Antioxidant Potentials of T. indica and its Environmental Application: A Mini Review
Current Biotechnology Cardiovascular Effects of Micromeria graeca (L.) Benth. ex Rchb in Normotensive and Hypertensive Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Angiogenesis Inhibitors and Vascular Disrupting Agents in Non-Small Cell Lung Cancer
Current Medicinal Chemistry Smoking, Estradiol Metabolism and Hormone Replacement Therapy
Current Medicinal Chemistry - Cardiovascular & Hematological Agents The First Line of Defense Against Cardiac Hypertrophy
Current Molecular Medicine Congenital Anomalies of the Urinary Tract
Current Pediatric Reviews Leptin and Vascular Smooth Muscle
Current Vascular Pharmacology Innovative Strategy in Treating Angina Pectoris with Chinese Patent Medicines by Promoting Blood Circulation and Removing Blood Stasis: Experience from Combination Therapy in Chinese Medicine
Current Vascular Pharmacology About Mechanism of Gas Transport Function and Side Reactions of Perfluorocarbon Nano-dispersions
Current Bionanotechnology (Discontinued) General Principles for the Treatment of Non-Infectious Uveitis
Inflammation & Allergy - Drug Targets (Discontinued) Metabolic Syndrome X is a Low-Grade Systemic Inflammatory Condition with its Origins in the Perinatal Period
Current Nutrition & Food Science The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options?
Current Vascular Pharmacology Cardiovascular Physiology of Androgens and Androgen Testosterone Therapy in Postmenopausal Women
Endocrine, Metabolic & Immune Disorders - Drug Targets Relation between the Change in Mean Platelet Volume and Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Intervention
Current Vascular Pharmacology Phenotyping of Chronic Obstructive Pulmonary Disease: Current Approaches and Future Directions
Current Respiratory Medicine Reviews Clinical Pharmacology of Trastuzumab
Current Clinical Pharmacology